Structural Heart Imaging Market

Market Overview:

The global structural heart imaging market size reached US$ 17.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 32.2 Billion by 2028, exhibiting a growth rate (CAGR) of 10.2% during 2023-2028.

Structural heart imaging (SHI) is a special technique, which is extensively deployed in the healthcare industry for screening and examining the heart at the molecular level. This procedure includes the utilization of light reflection for producing the interior element images and creating a 2-dimensional cross-section analysis to get a clarified and accurate diagnosis. It is further used for enabling and assisting professionals while performing various operative procedures, such as locating the blockages and pathways for insertion by minimizing the risk of interference.

Structural Heart Imaging Market Trends:

The escalating prevalence of various congenital, cardiac diseases and lifestyle-induced ailments, such as obesity, diabetes, and high blood pressure due to excessive alcohol consumption and unhealthy eating habits, is one of the primary factors majorly driving the global heart imaging market toward the growth. Furthermore, the rising health consciousness amongst the consumers is positively influencing the market across the globe. In addition to this, the widespread adoption of SHI for addressing various heart conditions, such as non-valvular and valvular heart diseases, with the support of high precision and resolution cameras and sensors is considerably contributing to the market growth. Moreover, the introduction of transcatheter aortic valve replacement (TAVR) for operating heart diseases interventions by ensuring instant recovery of consumers post-surgery is promoting the growth of the market. Other than this, the rising investments in research and development (R&D) activities for introducing advanced structural heart imaging and cardiac systems is creating a positive outlook for the market. In line with this, the market is further being driven by the numerous initiatives undertaken by the governments of various nations for improving the healthcare infrastructure to ensure patients wellness.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global structural heart imaging market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on imaging modality, procedure type, application and end user.

Breakup by Imaging Modality:

• Echocardiogram
• Angiogram

• CT
• MRI
   

Breakup by Procedure Type:

• Transcatheter Aortic Valve Replacement (TAVR)
• Surgical Aortic Valve Replacement (SAVR)
• Transcatheter Mitral Valve Repair (TMVR)
• Left Atrial Appendage Closure (LAAC)
• Annuloplasty
• Valvuloplasty
• Others
   

Breakup by Application:

• Diagnosis
• Surgery
   

Breakup by End User:

• Hospitals
• Specialty Clinics
• Cardiac Centers
• Diagnostic Centers
• Ambulatory Surgical Centers
• Catheterization Laboratories
• Others
   

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Boston Scientific Corporation, Circle Cardiovascular Imaging Inc., Edwards Lifesciences Corporation, Integer Holdings Corporation, Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co. Ltd., LivaNova PLC, Medtronic plc, Pie Medical Imaging B.V. and Siemens Healthcare GmbH.

Report Coverage: